Edit
Cambridge Cancer Genomics
http://www.ccg.ai/Last activity: 21.07.2020
Active - Reference to Dante Labs UK
Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response.
We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance.
We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance.
Location: United Kingdom, England, Cambridge
Employees: 11-50
Founded date: 2017
Investors 7
Mentions in press and media 6
| Date | Title | Description |
| 24.07.2019 | Could The NHS Really Sell Its Data For $12 Billion? | EY estimates that the value of the curated NHS dataset could be as much as £5 billion ($6.2 billion)... [+] per annum and deliver around £4.6 billion ($5.7 billoin) of benefit to patients per annum in potential operational savings for the N... |
| 13.12.2018 | Companies tracking mutations in cancer cells can provide a key to unlocking better therapies | Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can create more targeted therapies. Earlier this ... |
| 02.08.2018 | A different path to growth: VC Pi Campus invests in AI startups co-founded by researchers and designers | “This is not the Silicon Valley of Italy. We are different” says serial entrepreneur and investor Marco Trombetti, sitting at a table in the Adriano Olivetti Cafeteria, where people gather to have lunch together at Pi Campus, a seed venture... |
| 26.01.2018 | Who made the shortlist for SXSW Accelerator pitch competition? | Cambridge Cancer Genomics has developed blood tests to inform and support targeted cancer therapies. The goal is to reduce the time it takes to determine whether chemotherapy is working from the current timeframe of six months. Reducing tha... |
| 22.08.2017 | Cambridge Cancer Genomics offers a better way to gauge effective cancer treatments | John Cassidy’s family has been at the forefront of cancer research for three generations now. The Cambridge-educated co-founder and chief executive officer of cancer diagnostics company Cambridge Cancer Genomics was just following in his fa... |
| - | Who made the shortlist for SXSW Accelerator pitch competition? | Each year at the SXSW Interactive festival in Austin, early stage companies across multiple industries compete in a pitch competition. This year’s finalists in the health and wellness track reflect not only the convergence between life scie... |